SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-19-017023
Filing Date
2019-03-29
Accepted
2019-03-29 16:42:25
Documents
2
Period of Report
2019-03-29

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tv517594_6k.htm 6-K 10419
2 EXHIBIT 99.1 tv517594_ex99-1.htm EX-99.1 14780
  Complete submission text file 0001144204-19-017023.txt   26397
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-36288 | Film No.: 19717024
SIC: 2834 Pharmaceutical Preparations